APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trastuzumab

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Trastuzumab Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchTrastuzumab Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Trastuzumab Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Trastuzumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trastuzumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Trastuzumab Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Trastuzumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Trastuzumab market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Trastuzumab market include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Trastuzumab market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Trastuzumab and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Trastuzumab sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Trastuzumab market size, projected growth trends, production technologies, key applications, and end-use industries.

Trastuzumab Segment by Company

Novartis AG

Pfizer

InvivoGen

Genentech Inc

Celltrion

Bio-Techne

Biocon Limited

Abnova Corporation

Trastuzumab Segment by Type

Human Source

Animal Source

Trastuzumab Segment by Application

Hospital

Medical Center

Trastuzumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Trastuzumab status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Trastuzumab market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Trastuzumab significant trends, drivers, influence factors in global and regions.

6. To analyze Trastuzumab competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Trastuzumab market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Trastuzumab industry.

Chapter 3: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Trastuzumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Trastuzumab in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Trastuzumab Industry Trends Table 2. Trastuzumab Industry Drivers Table 3. Trastuzumab Industry Opportunities and Challenges Table 4. Trastuzumab Industry Restraints Table 5. Global Trastuzumab Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Trastuzumab Revenue Share by Company (2021-2026) Table 7. Global Trastuzumab Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Trastuzumab Sales Volume Share by Company (2021-2026) Table 9. Global Trastuzumab Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Trastuzumab Company Ranking, (2024-2026) & (USD Million) Table 11. Global Trastuzumab Key Company Manufacturing Base & Headquarters Table 12. Global Trastuzumab Company, Product Type & Application Table 13. Global Trastuzumab Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Trastuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Human Source Table 18. Significant Companies of Animal Source Table 19. Global Trastuzumab Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Trastuzumab Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Trastuzumab Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Trastuzumab Sales Volume Share by Type (2021-2026) Table 23. Global Trastuzumab Sales Volume Share by Type (2027-2032) Table 24. Global Trastuzumab Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Trastuzumab Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Trastuzumab Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Trastuzumab Sales Value Share by Type (2021-2026) Table 28. Global Trastuzumab Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Medical Center Table 31. Global Trastuzumab Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Trastuzumab Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Trastuzumab Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Trastuzumab Sales Volume Share by Application (2021-2026) Table 35. Global Trastuzumab Sales Volume Share by Application (2027-2032) Table 36. Global Trastuzumab Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Trastuzumab Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Trastuzumab Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Trastuzumab Sales Value Share by Application (2021-2026) Table 40. Global Trastuzumab Sales Value Share by Application (2027-2032) Table 41. Global Trastuzumab Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Trastuzumab Sales by Region (2021-2026) & (Tons) Table 43. Global Trastuzumab Sales Market Share by Region (2021-2026) Table 44. Global Trastuzumab Sales by Region (2027-2032) & (Tons) Table 45. Global Trastuzumab Sales Market Share by Region (2027-2032) Table 46. Global Trastuzumab Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Trastuzumab Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Trastuzumab Sales Value Share by Region (2021-2026) Table 49. Global Trastuzumab Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Trastuzumab Sales Value Share by Region (2027-2032) Table 51. Global Trastuzumab Market Average Price (US$/Ton) by Region (2021-2026) Table 52. Global Trastuzumab Market Average Price (US$/Ton) by Region (2027-2032) Table 53. Global Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Trastuzumab Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Trastuzumab Sales by Country (2021-2026) & (Tons) Table 56. Global Trastuzumab Sales Market Share by Country (2021-2026) Table 57. Global Trastuzumab Sales by Country (2027-2032) & (Tons) Table 58. Global Trastuzumab Sales Market Share by Country (2027-2032) Table 59. Global Trastuzumab Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Trastuzumab Sales Value Market Share by Country (2021-2026) Table 61. Global Trastuzumab Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Trastuzumab Sales Value Market Share by Country (2027-2032) Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Novartis AG Trastuzumab Product Portfolio Table 67. Novartis AG Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Pfizer Trastuzumab Product Portfolio Table 72. Pfizer Recent Development Table 73. InvivoGen Company Information Table 74. InvivoGen Business Overview Table 75. InvivoGen Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. InvivoGen Trastuzumab Product Portfolio Table 77. InvivoGen Recent Development Table 78. Genentech Inc Company Information Table 79. Genentech Inc Business Overview Table 80. Genentech Inc Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Genentech Inc Trastuzumab Product Portfolio Table 82. Genentech Inc Recent Development Table 83. Celltrion Company Information Table 84. Celltrion Business Overview Table 85. Celltrion Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Celltrion Trastuzumab Product Portfolio Table 87. Celltrion Recent Development Table 88. Bio-Techne Company Information Table 89. Bio-Techne Business Overview Table 90. Bio-Techne Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Bio-Techne Trastuzumab Product Portfolio Table 92. Bio-Techne Recent Development Table 93. Biocon Limited Company Information Table 94. Biocon Limited Business Overview Table 95. Biocon Limited Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Biocon Limited Trastuzumab Product Portfolio Table 97. Biocon Limited Recent Development Table 98. Abnova Corporation Company Information Table 99. Abnova Corporation Business Overview Table 100. Abnova Corporation Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Abnova Corporation Trastuzumab Product Portfolio Table 102. Abnova Corporation Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Trastuzumab Distributors List Table 106. Trastuzumab Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Trastuzumab Product Image Figure 2. Global Trastuzumab Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 4. Global Trastuzumab Sales (2021-2032) & (Tons) Figure 5. Global Trastuzumab Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Trastuzumab Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Human Source Image Figure 10. Animal Source Image Figure 11. Global Trastuzumab Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Trastuzumab Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Trastuzumab Sales Volume Share by Type (2021-2032) Figure 14. Global Trastuzumab Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Trastuzumab Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Trastuzumab Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Medical Center Image Figure 19. Global Trastuzumab Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Trastuzumab Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Trastuzumab Sales Volume Share by Application (2021-2032) Figure 22. Global Trastuzumab Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Trastuzumab Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Trastuzumab Sales Value Share by Application (2021-2032) Figure 25. Global Trastuzumab Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Trastuzumab Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Trastuzumab Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Trastuzumab Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 30. North America Trastuzumab Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Trastuzumab Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Trastuzumab Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 36. South America Trastuzumab Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Trastuzumab Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Trastuzumab Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Trastuzumab Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Trastuzumab Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Trastuzumab Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Trastuzumab Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Trastuzumab Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Human Source
  • Animal Source
Applications
  • Hospital
  • Medical Center
Companies covered
  • Novartis AG
  • Pfizer
  • InvivoGen
  • Genentech Inc
  • Celltrion
  • Bio-Techne
  • Biocon Limited
  • Abnova Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Trastuzumab Sales Value (2021-2032)
  4. 1.2.2 Global Trastuzumab Sales Volume (2021-2032)
  5. 1.2.3 Global Trastuzumab Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Trastuzumab Market Dynamics
  1. 2.1 Trastuzumab Industry Trends
  2. 2.2 Trastuzumab Industry Drivers
  3. 2.3 Trastuzumab Industry Opportunities and Challenges
  4. 2.4 Trastuzumab Industry Restraints
3 Trastuzumab Market by Company
  1. 3.1 Global Trastuzumab Company Revenue Ranking in 2025
  2. 3.2 Global Trastuzumab Revenue by Company (2021-2026)
  3. 3.3 Global Trastuzumab Sales Volume by Company (2021-2026)
  4. 3.4 Global Trastuzumab Average Price by Company (2021-2026)
  5. 3.5 Global Trastuzumab Company Ranking (2024-2026)
  6. 3.6 Global Trastuzumab Company Manufacturing Base and Headquarters
  7. 3.7 Global Trastuzumab Company Product Type and Application
  8. 3.8 Global Trastuzumab Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Trastuzumab Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Trastuzumab Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Trastuzumab Market by Type
  1. 4.1 Trastuzumab Type Introduction
  2. 4.1.1 Human Source
  3. 4.1.2 Animal Source
  4. 4.2 Global Trastuzumab Sales Volume by Type
  5. 4.2.1 Global Trastuzumab Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Trastuzumab Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Trastuzumab Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Trastuzumab Sales Value by Type
  9. 4.3.1 Global Trastuzumab Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Trastuzumab Sales Value by Type (2021-2032)
  11. 4.3.3 Global Trastuzumab Sales Value Share by Type (2021-2032)
5 Trastuzumab Market by Application
  1. 5.1 Trastuzumab Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Center
  4. 5.2 Global Trastuzumab Sales Volume by Application
  5. 5.2.1 Global Trastuzumab Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Trastuzumab Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Trastuzumab Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Trastuzumab Sales Value by Application
  9. 5.3.1 Global Trastuzumab Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Trastuzumab Sales Value by Application (2021-2032)
  11. 5.3.3 Global Trastuzumab Sales Value Share by Application (2021-2032)
6 Trastuzumab Regional Sales and Value Analysis
  1. 6.1 Global Trastuzumab Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Trastuzumab Sales by Region (2021-2032)
  3. 6.2.1 Global Trastuzumab Sales by Region: 2021-2026
  4. 6.2.2 Global Trastuzumab Sales by Region (2027-2032)
  5. 6.3 Global Trastuzumab Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Trastuzumab Sales Value by Region (2021-2032)
  7. 6.4.1 Global Trastuzumab Sales Value by Region: 2021-2026
  8. 6.4.2 Global Trastuzumab Sales Value by Region (2027-2032)
  9. 6.5 Global Trastuzumab Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Trastuzumab Sales Value (2021-2032)
  12. 6.6.2 North America Trastuzumab Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Trastuzumab Sales Value (2021-2032)
  15. 6.7.2 Europe Trastuzumab Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Trastuzumab Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Trastuzumab Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Trastuzumab Sales Value (2021-2032)
  21. 6.9.2 South America Trastuzumab Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Trastuzumab Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Trastuzumab Sales Value Share by Country, 2025 VS 2032
7 Trastuzumab Country-level Sales and Value Analysis
  1. 7.1 Global Trastuzumab Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Trastuzumab Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Trastuzumab Sales by Country (2021-2032)
  4. 7.3.1 Global Trastuzumab Sales by Country (2021-2026)
  5. 7.3.2 Global Trastuzumab Sales by Country (2027-2032)
  6. 7.4 Global Trastuzumab Sales Value by Country (2021-2032)
  7. 7.4.1 Global Trastuzumab Sales Value by Country (2021-2026)
  8. 7.4.2 Global Trastuzumab Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Trastuzumab Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Trastuzumab Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Trastuzumab Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Trastuzumab Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Trastuzumab Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Trastuzumab Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Trastuzumab Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Trastuzumab Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Trastuzumab Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Trastuzumab Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Trastuzumab Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Trastuzumab Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Trastuzumab Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Trastuzumab Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Trastuzumab Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Trastuzumab Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Trastuzumab Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Trastuzumab Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Trastuzumab Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Trastuzumab Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Trastuzumab Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Trastuzumab Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Trastuzumab Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Trastuzumab Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Trastuzumab Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Trastuzumab Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Trastuzumab Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Trastuzumab Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Trastuzumab Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Trastuzumab Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Trastuzumab Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Trastuzumab Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Trastuzumab Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Trastuzumab Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Trastuzumab Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Trastuzumab Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Trastuzumab Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Trastuzumab Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Trastuzumab Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Trastuzumab Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Trastuzumab Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Trastuzumab Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Trastuzumab Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Trastuzumab Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Trastuzumab Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Trastuzumab Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Trastuzumab Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Trastuzumab Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Trastuzumab Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Trastuzumab Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Trastuzumab Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Trastuzumab Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Trastuzumab Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Trastuzumab Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Trastuzumab Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Trastuzumab Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Trastuzumab Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Trastuzumab Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Trastuzumab Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Trastuzumab Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Trastuzumab Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Trastuzumab Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Trastuzumab Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Trastuzumab Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Trastuzumab Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Trastuzumab Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Trastuzumab Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Trastuzumab Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Trastuzumab Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Trastuzumab Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Trastuzumab Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Trastuzumab Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Trastuzumab Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Trastuzumab Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Trastuzumab Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Trastuzumab Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Trastuzumab Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Trastuzumab Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Trastuzumab Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Trastuzumab Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Trastuzumab Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Trastuzumab Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Trastuzumab Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Trastuzumab Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Trastuzumab Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Trastuzumab Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Trastuzumab Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Trastuzumab Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 InvivoGen
  14. 8.3.1 InvivoGen Company Information
  15. 8.3.2 InvivoGen Business Overview
  16. 8.3.3 InvivoGen Trastuzumab Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 InvivoGen Trastuzumab Product Portfolio
  18. 8.3.5 InvivoGen Recent Developments
  19. 8.4 Genentech Inc
  20. 8.4.1 Genentech Inc Company Information
  21. 8.4.2 Genentech Inc Business Overview
  22. 8.4.3 Genentech Inc Trastuzumab Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Genentech Inc Trastuzumab Product Portfolio
  24. 8.4.5 Genentech Inc Recent Developments
  25. 8.5 Celltrion
  26. 8.5.1 Celltrion Company Information
  27. 8.5.2 Celltrion Business Overview
  28. 8.5.3 Celltrion Trastuzumab Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Celltrion Trastuzumab Product Portfolio
  30. 8.5.5 Celltrion Recent Developments
  31. 8.6 Bio-Techne
  32. 8.6.1 Bio-Techne Company Information
  33. 8.6.2 Bio-Techne Business Overview
  34. 8.6.3 Bio-Techne Trastuzumab Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Techne Trastuzumab Product Portfolio
  36. 8.6.5 Bio-Techne Recent Developments
  37. 8.7 Biocon Limited
  38. 8.7.1 Biocon Limited Company Information
  39. 8.7.2 Biocon Limited Business Overview
  40. 8.7.3 Biocon Limited Trastuzumab Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biocon Limited Trastuzumab Product Portfolio
  42. 8.7.5 Biocon Limited Recent Developments
  43. 8.8 Abnova Corporation
  44. 8.8.1 Abnova Corporation Company Information
  45. 8.8.2 Abnova Corporation Business Overview
  46. 8.8.3 Abnova Corporation Trastuzumab Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Abnova Corporation Trastuzumab Product Portfolio
  48. 8.8.5 Abnova Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Trastuzumab Value Chain Analysis
  2. 9.1.1 Trastuzumab Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Trastuzumab Sales Mode & Process
  6. 9.2 Trastuzumab Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Trastuzumab Distributors
  9. 9.2.3 Trastuzumab Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst